|
|
||||||||

* Department of Human Health and Nutritional Sciences, University of Guelph, Guelph, Ontario, Canada N1G 2W1; and
Ontario Cancer Institute, Division of Stem Cell and Differentiation, University Health Network, Toronto, Ontario, Canada M5G 2M1
To whom requests for reprints should be addressed at 1 Animal Science and Nutrition Building, Rm. 346, University of Guelph, Guelph, Ontario, Canada N1G 2W1. E-mail: mbakovic{at}uoguelph.ca
Choline is an essential nutrient for all cells because it plays a role in the synthesis of the membrane phospholipid components of the cell membranes, as a methyl-group donor in methionine metabolism as well as in the synthesis of the neurotransmitter acetylcholine. Choline deficiency affects the expression of genes involved in cell proliferation, differentiation, and apoptosis, and it has been associated with liver dysfunction and cancer. Abnormal choline transport and metabolism have been implicated in a number of neurodegenerative disorders such as Alzheimers and Parkinsons disease. Therefore, the study of choline transport and the characteristics of choline transporters are of central importance to understanding the mechanisms that underlie membrane integrity and cell signaling in such disorders. Kinetic studies with radiolabeled choline and inhibitors distinguish three systems for choline transport: (i) low-affinity facilitated diffusion, (ii) high-affinity, Na+-dependent transport, and (iii) intermediate-affinity, Na+-independent transport. It is only recently, however, that the proteins having transport characteristics of at least one of these systems have been identified. They include (i) polyspecific organic cation transporters (OCTs) with low affinity for choline, (ii) high-affinity choline transporters (CHT1s), and (iii) intermediate-affinity choline transporter-like (CTL1) proteins. CHT1 and CTL1 but not OCT transporters are selectively inhibited with hemicholinium-3 and essentially display characteristics of specialized transporters for targeted choline metabolism. CHT1 is abundant in neurons and almost exclusively supplies choline for acetyl-choline synthesis. The focus here is more on newly-discovered CTL1 choline transporters. They are expressed in different organisms and cell types, apparently not for the biosynthesis of acetylcholine but for the production of the most abundant metabolite of choline, the membrane lipid phosphatidylcholine.
Key Words: choline phospholipids choline transport CTL1
This article has been cited by other articles:
![]() |
A. Dahlin, J. Royall, J. G. Hohmann, and J. Wang Expression Profiling of the Solute Carrier Gene Family in the Mouse Brain J. Pharmacol. Exp. Ther., May 1, 2009; 329(2): 558 - 570. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. von Forstner, J.-H. Egberts, O. Ammerpohl, D. Niedzielska, R. Buchert, P. Mikecz, U. Schumacher, K. Peldschus, G. Adam, C. Pilarsky, et al. Gene Expression Patterns and Tumor Uptake of 18F-FDG, 18F-FLT, and 18F-FEC in PET/MRI of an Orthotopic Mouse Xenotransplantation Model of Pancreatic Cancer J. Nucl. Med., August 1, 2008; 49(8): 1362 - 1370. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Plathow and W. A. Weber Tumor Cell Metabolism Imaging J. Nucl. Med., June 1, 2008; 49(Suppl_2): 43S - 63S. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Orlacchio, F. Bolacchi, M. Cadioli, A. Bergamini, V. Cozzolino, M. Angelico, and G. Simonetti Evaluation of the Severity of Chronic Hepatitis C with 3-T1H-MR Spectroscopy Am. J. Roentgenol., May 1, 2008; 190(5): 1331 - 1339. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Signore, P. M. Ueland, J. Troendle, and J. L Mills Choline concentrations in human maternal and cord blood and intelligence at 5 y of age Am. J. Clinical Nutrition, April 1, 2008; 87(4): 896 - 902. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Wu, C. Aoyama, S. G. Young, and D. E. Vance Early Embryonic Lethality Caused by Disruption of the Gene for Choline Kinase {alpha}, the First Enzyme in Phosphatidylcholine Biosynthesis J. Biol. Chem., January 18, 2008; 283(3): 1456 - 1462. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |